In contrast, targeted deletion of Galectin-3 exacerbated ischemic brain injury and neurodegeneration after cerebral ischemia (Lalancette-Hebert et al., 2012) suggesting a neuroprotective role of Gelectin-3 after brain damage. The gene discussed is LGALS3; the disease is Cerebral ischemia.